A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Infants and Toddlers
Conditions
- Meningitis
- Meningococcal Infection
Interventions
- BIOLOGICAL: Quadrivalent Meningococcal Polysaccharide (A, C, Y, and W-135) Tetanus Protein Conjugate
- BIOLOGICAL: Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus B Conjugate (Tetanus Toxoid Conjugate) Vaccine Combined (DTaP-IPV/Hib combined)
- BIOLOGICAL: M-M-RII-Measles, Mumps, and Rubella Virus Vaccine Live
- BIOLOGICAL: Varicella Virus Vaccine Live
- BIOLOGICAL: Pneumococcal 7-valent Conjugate Vaccine (Diphtheria CRM197 Protein)
- BIOLOGICAL: Pneumococcal 13-valent Conjugate Vaccine (Diphtheria CRM197 Protein)
- BIOLOGICAL: Rotavirus Vaccine
- BIOLOGICAL: Hepatitis B Vaccine
Sponsor
Sanofi Pasteur, a Sanofi Company